Acceder Registro /

Francisco MARIN ORTUÑO

Buscador

Payá E, Marín F, González J, Gimeno JR, Feliu E, Romero A, Ruiz-Espejo F, Roldán V, Climent V, de la Morena G, Valdés M. Variables associated with contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: clinical implications. J Card Fail. 2008 Jun;14(5):414-9. doi: 10.1016/j.cardfail.2008.02.006. Epub 2008 May 27. PubMed PMID: 18514934.
AÑO: 2008; IF: 3.691
Roldán V, Marín F, Gimeno JR, Ruiz-Espejo F, González J, Feliu E, García-Honrubia A, Saura D, de la Morena G, Valdés M, Vicente V. Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy. Am Heart J. 2008 Jul;156(1):85-91. doi: 10.1016/j.ahj.2008.01.035. PubMed PMID: 18585501.
AÑO: 2008; IF: 4.285
Roldán V, Marín F, González-Conejero R, García-Honrubia A, Martí S, Alfaro A, Valdés M, Corral J, Lip GY, Vicente V. Factor VII -323 decanucleotide D/I polymorphism in atrial fibrillation: implications for the prothrombotic state and stroke risk. Ann Med. 2008;40(7):553-9. doi: 10.1080/07853890802108412. PubMed PMID: 18608122.
AÑO: 2008; IF: 5.435
Pineda J, Marín F, Marco P, Roldán V, Valencia J, Ruiz-Nodar JM, Sogorb F, Lip GY. Int J Cardiol. 2009 Aug 14;136(2):222-5. doi: 10.1016/j.ijcard.2008.04.020. Epub 2008 Jul 14. PubMed PMID: 18625524.
AÑO: 2009; IF: 3.469
Manzano-Fernández S, Pastor FJ, Marín F, Cambronero F, Caro C, Pascual-Figal DA, Garrido IP, Pinar E, Valdés M, Lip GY. Increased major bleeding complications related to triple antithrombotic therapy usage in patients with atrial fibrillation undergoing percutaneous coronary artery stenting. Chest. 2008 Sep;134(3):559-67. doi: 10.1378/chest.08-0350. Epub 2008 Jul 18. PubMed PMID: 18641090.
AÑO: 2008; IF: 5.154

Instituto de Investigación Sanitaria Acreditado

ISCII

Fondo Social Europeo "El FSE Invierte en tu futuro"

Fondo Social Europeo

Sello de Calidad Europeo "HR Excellence in Research"

HRS4R